Psychotherapeutic and pharmacological treatment of pediatric obsessive-compulsive disorder;Psychotherapeutische und medikamentöse Behandlung der kindlichen Zwangsstörung

Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie

Volumn 40, Issue 1, 2012, Pages 29-40

  Vloet, Timo D ^a   Simons, Michael ^a   Herpertz Dahlmann, Beate ^a,b  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b JARA Translational Brain Medicine   (Germany)

Author keywords

Adolescent; Child; Obsessive compulsive disorder; Psychopharmacotherapy; Psychotherapy

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CLOMIPRAMINE; CYCLOSERINE; RILUZOLE; SEROTONIN UPTAKE INHIBITOR;

CLINICAL EFFECTIVENESS; COGNITIVE THERAPY; HABITUATION; HUMAN; OBSESSIVE COMPULSIVE DISORDER; PSYCHOPHARMACOTHERAPY; PSYCHOTHERAPY; REVIEW; TREATMENT PLANNING;

ADOLESCENT; ANTIPSYCHOTIC AGENTS; CHILD; CLOMIPRAMINE; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; CYCLOSERINE; DRUG THERAPY, COMBINATION; EXCITATORY AMINO ACID ANTAGONISTS; HUMANS; IMPLOSIVE THERAPY; OBSESSIVE-COMPULSIVE DISORDER; RILUZOLE; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 84855554023     PISSN: 14224917     EISSN: None     Source Type: Journal    
DOI: 10.1024/1422-4917/a000147     Document Type: Review

References (70)

1. Abramowitz, J. S., Wheaton, M. G. & Storch, E. A. (2008). The status of hoarding as a symptom of obsessive-compulsive disorder. Behaviour Research Therapy, 46, 1026-1033.
2. Alaghband-Rad, J. & Hakimshooshtary, M. (2009). A randomized controlled clinical trial of citalopram versus fluoxetine in children and adolescents with obsessive-compulsive disorder (OCD). European Child and Adolescent Psychiatry, 18, 131-135.
3. American Psychiatric Association. (2000). Diagnostic and Statistical Manual of Mental Disorders. Text revision (DSM-IVTR) (4th ed.). Washington, DC: Author.
4. Ansorge, M. S., Morelli, E. & Gingrich, J. A. (2008). Inhibition of serotonin but not norepinephrine transport during development produces delayed, persistent perturbations of emotional behaviors in mice. Journal of Neuroscience, 28, 199-207.
5. Arnold, P. D., Sicard, T., Burroughs, E., Richter, M. A. & Kennedy, J. L. (2006). Glutamate transporter gene SLC1A1 associated with obsessive-compulsive disorder. Archives of General Psychiatry, 3, 717-720.
6. Bandelow, B., Heise C. A., Banaschewski, T. & Rothenberger, A. (2006). Handbuch Psychopharmaka für das Kindes- und Jugendalter. Göttingen: Hogrefe.
7. Bloch, M. H., Landeros-Weisenberger, A., Kelmendi, B., Coric, V., Bracken, M. B. & Leckman, J. F. (2006). A systematic review: Antipsychotic augmentationwith treatment refractory obsessive-compulsive disorder. Molecular Psychiatry, 11, 622-632. (Pubitemid 43989810)
8. Bloch, M. H., McGuire, J., Landeros-Weisenberger, A., Leckman, J. F. & Pittenger, C. (2010). Meta-analysis of the dose-response relationship of SSRI in obsessive-compulsive disorder. Molecular Psychiatry, 15, 850-855.
9. Bridge, J., Iyengar, S., Salary, C. B., Barbe, R. P., Birmaher, B., Pincus, H. A. . . . Brent, D. A. (2007). Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: A meta-analysis of randomized controlled trials. Journal of the American Medical Association, 297, 1683-1696.
10. Casey, B. J., Tottenham, N. & Fossella, J. (2002). Clinical, imaging, lesion, and genetic approaches toward a model of cognitive control. Developmental Psychobiology, 40, 237-254. (Pubitemid 34651292)
11. Chabane, N., Delorme, R., Millet, B., Mouren, M. C., Leboyer, M. & Pauls, D. (2005). Early-onset obsessive-compulsive disorder: A subgroup with a specific clinical and familial pattern? Journal of Child Psychology and Psychiatry, 46, 881-887. (Pubitemid 41633094)
12. Craske, M. G., Kircanski, K., Zelikowsky, M., Mystkowski, J., Chowdhury, N. & Baker, A. (2008). Optimizing inhibitory learning during exposure therapy. Behaviour Research and Therapy, 46, 5-27.
13. Figueroa, Y., Rosenberg, D., Birmaher, B. & Keshavan, M. (1998). Combination treatment with Clomipramine and selective serotonin reuptake inhibitors for obsessive-compulsive disorder in children and adolescents. Journal of Child and Adolescent Psychopharmacology, 8, 61-67. (Pubitemid 28270779)
14. Fineberg, N. A., Pampaloni, I., Pallanti, S., Ipser, J. & Stein, D. J. (2007). Sustained response versus relapse: The pharmacotherapeutic goal for obsessive-compulsive disorder. International Clinical Psychopharmacology, 22, 313-322. (Pubitemid 47530835)
15. Flament, M. F., Whitaker, A., Rapoport, J. L., Davies, M., Berg, C. Z., Kalikow, K. . . . Shaffer, D. (1988). Obsessive compulsive disorder in adolescence: An epidemiological study. Journal of the American Academy of Child and Adolescent Psychiatry, 27, 764-771. (Pubitemid 19003719)
16. Foa, E. B., Coles, M., Huppert, J. D., Pasupuleti, R. V., Franklin, M. E. & March, J. (2010). Behavior Therapy, 41, 121-132.
17. Garcia, A. M., Sapyta, J. L., Moore, P. S., Freeman, J. B., Franklin, M. E., March, J. S. & Foa, E. B. (2010). Predictors and moderators of treatment outcome in the Pediatric Obsessive Compulsive Treatment Study (POTS I). Journal of the American Academy of Child and Adolescent Psychiatry, 49, 1024-1033.
18. Geller, D., Biederman, J., Faraone, S. V., Bellorde, C. A., Kim, G. S. & Hagermoser, L. M. (2001) Disentangling chronological age from age of onset in children and adolescents with obsessive compulsive disorder. International Journal of Neuropsychopharmacology, 4, 169-178. (Pubitemid 32587385)
19. Geller, D. A., Biederman, J., Stewart, S. E., Mullin, B., Martin, A., Spencer, T. & Faraone, S. V. (2003).Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder. American Journal of Psychiatry, 160, 1919-1928. (Pubitemid 39619624)
20. Geller, D. A., Wagner, K. D., Emslie, G., Murphy, T., Carpenter, D. J., Wetherhold, E. . . . Gardiner, C. (2004). Paroxetine treatment in children and adolescents with obsessive-compulsive disorder: A randomized, multicenter, double-blind, placebo-controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry, 43, 1387-1396. (Pubitemid 39411039)
21. Gilbert, A. R. & Maalouf, F. T. (2008). Pediatric obsessive-compulsive disorder: Management in primary care. Current Opinion in Pediatrics, 20, 544-550.
22. Grados, M., Scahill, L. & Riddle, M. A. (1999). Pharmacotherapy in children and adolescents with obsessive-compulsive disorder. Child and Adolescent Psychiatric Clinics of North America, 8, 617-634. (Pubitemid 29360211)
23. Grant, P., Lougee, L., Hirschtritt, M. & Swedo, S. E. (2007). An open-label trial of riluzole, a glutamate antagonist, in children with treatment-resistant obsessive-compulsive disorder. Journal of Child Adolescent Psychopharmacology, 17, 761-767. (Pubitemid 351158597)
24. Grant, P., Song, J. Y. & Swedo, S. E. (2010). Review of the use of the glutamate antagonist riluzole in psychiatric disorders and a description of recent use in childhood obsessive-compulsive disorder. Journal of Child and Adolescent Psychopharmacology, 20, 309-315.
25. Hanna, G. L., Fischer, D. J., Chadha, K. R., Himle, J. A. & Van Etten, M. (2005). Familial and sporadic subtypes of early-onset Obsessive-Compulsive disorder. Biological Psychiatry, 57, 895-900. (Pubitemid 40488358)
26. Hezel, D. M., Beattie, K. & Stewart, S. E. (2009). Memantine as an augmenting agent for severe pediatric OCD. American Journal of Psychiatry, 166, 237.
27. Hollander, E., Kim, S., Braun, A., Simeon, D. & Zohar, J. (2009). Cross-cutting issues and future directions for the OCD spectrum. Psychiatry Research, 170, 3-6.
28. Hollander, E., Stein, D. J., Fineberg, N. A., Marteau, F. & Legault, M. (2010). Quality of life outcomes in patients with obsessive-compulsive disorder: Relationship to treatment response and symptom relapse. Journal of Clinical Psychiatry, 71, 784-792.
29. Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R. & Walters, E. E. (2005). Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry, 62, 593-602. (Pubitemid 40973434)
30. Kessler, R. C., Chiu, W. T., Demler, O., Merikangas, K. R. & Walters, E. E. (2005). Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry, 62, 617-627. (Pubitemid 40973437)
31. Kobak, K. A., Greist, J. H., Jefferson, J. W., Katzelnick, D. J. & Henk, H. J. (1998). Behavioral versus pharmacological treatments of obsessive compulsive disorder:Ameta-analysis. Psychopharmacology (Berl), 136, 205-216. (Pubitemid 28143169)
32. Leonard, H. L., Swedo, S. E., Lenane, M. C., Rettew, D. C., Hamburger, S. D., Bartko, J. J. & Rapoport, J. L. (1993). A 2- to 7-year follow-up study of 54 obsessive-compulsive children and adolescents. Archives of General Psychiatry, 50, 429-439. (Pubitemid 23169936)
33. Mancuso, E., Faro, A., Joshi, G. & Geller, D. A. (2010). Treatment of pediatric obsessive-compulsive disorder: A review. Journal of Child and Adolescent Psychopharmacology, 20, 299-308.
34. March, J., Foa, E., Gammon, P., Chrisman, A., Curry, J., Fitzgerald, D. . . . Tu, X. (2004). Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: The Pediatric OCD Treatment Study (POTS) randomized controlled trial. Journal of the American Medical Association, 292, 1969-1976. (Pubitemid 39411205)
35. March, J., Franklin, M. E., Leonard, H., Garcia, A., Moore, P., Freeman, J. & Foa, E. (2007). Tics moderate treatment outcome with sertraline but not cognitive-behavior therapy in pediatric obsessive-compulsive disorder. Biological Psychiatry, 61, 344-347. (Pubitemid 46108694)
36. Martin, A., Young, C., Leckman, J. F., Mukonoweshuro, C., Rosenheck, R. & Douglas, L. (2004). Age effects of antidepressant- induced manic conversion. Archives of Paediatric and Adolescent Medicine, 158, 773-780. (Pubitemid 39025076)
37. Masi, G., Millepiedi, S., Mucci, M., Bertini, N., Pfanner, C. & Arcangeli, F. (2006). Comorbidity of obsessive-compulsive disorder and attention-deficit/hyperactivity disorder in referred children and adolescents. Comprehensive Psychiatry, 47, 42-47. (Pubitemid 41736149)
38. McDougle, C. J., Epperson, C. N., Pelton, G. H., Wasylink, S. & Price, L. H. (2000). A double-blind placebo-controlled study of risperidone addition in serotonin-reuptake inhibitor-refractory obsessive-compulsive disorder. Archives of General Psychiatry, 57, 794-801. (Pubitemid 30650116)
39. Micali, N., Heyman, I., Perez, M., Hilton, K., Nakatani, E., Turner, C. & Mataix-Cols, D. (2010). Long-term outcomes of obsessive-compulsive disorder: Follow-up of 142 children and adolescents. British Journal of Psychiatry, 197, 128-134.
40. Norberg, M. M., Krystal, J. H. & Tolin, D. F. (2008). A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy. Biological Psychiatry, 63, 1118-1126.
41. Pertusa, A., Fullana, M. A., Singh, S., Alonso, P., Menchon, J. M. & Mataix-Cols, D. (2008). Compulsive hoarding: OCD symptom, distinct clinical syndrome, or both? American Journal of Psychiatry, 165, 1289-1298.
42. Piacentini, J., Bergman, R. L., Keller, M. & McCracken, J. (2003). Functional impairment in children and adolescents with obsessive-compulsive disorder. Journal of Child and Adolescent Psychopharmacology, 13, S61-S69. (Pubitemid 36886095)
43. Remschmidt, H., Schmidt, M. & Poustka, F. (2006). Multiaxiales Klassifikationsschema für psychische Störungen desKindes- und Jugendalter nach ICD-10 der WHO (5. Aufl.). Bern: Huber.
44. Riddle, M. A., Reeve, E. A., Yaryura-Tobias, J. A., Yang, H. M., Claghorn, J. L., Gaffney, G. . . . Walkup, J. T. (2001). Fluvoxamine for children and adolescents with obsessive-compulsive disorder: A randomized, controlled, multicenter trial. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 222-229. (Pubitemid 32111026)
45. Saß, H., Wittchen, H. U., Zaudig, M. & Houben, I. (2003). Diagnostisches und Statistisches Manual Psychischer Störungen DSM-IV (4. Aufl.). Göttingen: Hogrefe.
46. Scahill, L., Riddle, M., McSwiggin-Hardin, M., Ort, S. I., King, R. A., Goodman, W. K. . . . Leckman, J. F. (1997). Children's Yale-Brown Obsessive Compulsive Scale: Reliability and validity. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 844-852. (Pubitemid 27250450)
47. Schrag, A., Gilbert, R., Giovannoni, G., Robertson, M. M., Metcalfe, C. & Ben-Shlomo, Y. (2009). Streptococcal infection, Tourette syndrome, and OCD: Is there a connection? Neurology, 73, 1256-1263.
48. Simons, M. & Herpertz-Dahlmann, B. (2003). Psychotherapie der Zwangsstörung bei Kindern und Jugendlichen - eine Übersicht. Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie, 31, 213-221. (Pubitemid 36958605)
49. Simons, M., Schneider, S. & Herpertz-Dahlmann, B. (2006). Metacognitive therapy versus exposure and response prevention for pediatric obsessive-compulsive disorder. A case series with randomized allocation. Psychotherapy and Psychosomatics, 75, 257-264. (Pubitemid 43938878)
50. Stein, D. J., Fineberg, N. A., Bienvenu, O. J., Denys, D., Lochner, C., Nestadt, G. . . . Phillips, K. A. (2010). Should OCD be classified as an anxiety disorder in DSM-V? Depression and Anxiety, 27, 495-506.
51. Stewart, S. E., Jenike, E. A., Hezel, D. M., Stack, D. E., Dodman, N. H., Shuster, L. & Jenike, M. A. (2010). A single-blinded case-control study of memantine in severe obsessive-compulsive disorder. Journal of Clinical Psychopharmacology, 30, 34-39.
52. Storch, E. A., Abramowitz, J. & Goodman, W. K. (2008). Where does obsessive-compulsive disorder belong in DSM-V? Depression and Anxiety, 25, 336-347. (Pubitemid 351614568)
53. Storch, E. A., Lewin, A. B., De Nadai, A. S., Murphy, T. K. (2010). Defining treatment response and remission in obsessive-compulsive disorder: A signal detection analysis of the Children's Yale-Brown Obsessive Compulsive Scale. Journal of the American Academy of Child and Adolescent Psychiatry, 49, 708-717.
54. Storch, E. A., Lewin, A. B., Geffken, G. R., Morgan, J. R. & Murphy, T. K. (2010). The role of comorbid disruptive behavior in the clinical expression of pediatric obsessive-compulsive disorder. Behaviour Research Therapy, 48, 1204-1210.
55. Storch, E. A., Murphy, T. K., Goodman, W. K., Geffken, G. R., Lewin, A. B., Henin, A. . . . Wilhelm, S. (2010). A preliminary study of D-cycloserine augmentation of cognitive-behavioral therapy in pediatric obsessive-compulsive disorder. Biological Psychiatry, 68, 1073-1076
56. Storch, E. A., Park, J. M., Lewin, A. B., Morgan, J. R., Jones, A. M. & Murphy, T. K. (2011). The Leyton Obsessional Inventory-Child Version Survey Form does not demonstrate adequate psychometric properties in American youth with pediatric obsessive-compulsive disorder. Journal of Anxiety Disorders, 25, 574-578.
57. Swedo, S. E., Leonard, H. L., Garvey, M., Mittleman, B., Allen, A. J., Perlmutter, S. . . . Dubbert, B. K. (1998). Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: Clinical description of the first 50 cases. American Journal of Psychiatry, 155, 264-271. (Pubitemid 28074291)
58. Unnewehr, S., Schneider, S. & Margraf, J. (Hrsg.). (1995). Diagnostisches Inventar bei psychischen Störungen im Kindes- und Jugendalter (Kinder-DIPS). Berlin: Springer.
59. Vloet, T., Neufang, S., Herpertz-Dahlmann, B. & Konrad, K. (2006). Bildgebungsbefunde bei Kindern und Jugendlichen mit ADHS, Tic-Störungen und Zwangserkrankungen. Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie, 34, 343-355. (Pubitemid 44510468)
60. Waite, P. & Williams, T. (Eds.). (2009). Obsessive compulsive disorder: Cognitive behaviour therapy with children and young people. Hove: Routledge.
61. Walitza, S., Melfsen, S., Jans, T., Zellmann, H., Wewetzer, C. & Warnke, A. (2011). Obsessive-compulsive disorder in children and adolescents. Deutsches Ärzteblatt International, 108, 173-179.
62. Watson, H. J. & Rees, C. S. (2008). Meta-analysis of randomized, controlled treatment trials for pediatric obsessive-compulsive disorder. Journal of Child Psychology and Psychiatry, 49, 489-498. (Pubitemid 351503099)
63. Wells, A. (1997). Cognitive therapy of anxiety disorders: A practice manual and conceptual guide. Chichester, UK: Wiley.
64. Wells, A. (2011). Metakognitive Therapie bei Angststörungen und Depression. Weinheim: Beltz.
65. Wewetzer, C., Jans, T., Müller, B., Neudörfl, A., Bucherl, U., Remschmidt, H. . . . Herpertz-Dahlmann, B. (2001). Long-term outcome and prognosis of obsessive-compulsive disorder with onset in childhood or adolescence. European Child and Adolescent Psychiatry, 10, 37-46. (Pubitemid 32268269)
66. Wewetzer, C., Mehler-Wex, C. & Warnke, A. (2003). Pharmakotherapie von Zwangsstörungen im Kindes- und Jugendalter. Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie, 31, 223-230. (Pubitemid 36958606)
67. Wewetzer, C., Simons, M., Konrad, K., Walitza, B. & Herpertz- Dahlmann, B. (2008). Zwangsstörungen. In B. Herpertz-Dahlmann, F. Resch, M. Schulte-Marktwort & A. Warnke (Eds.), Entwicklungspsychiatrie (2. Aufl., S. 719-743). Stuttgart: Schattauer.
68. Wilhelm, S., Buhlmann, U., Tolin, D. F., Meunier, S. A., Pearlson, G. D., Reese, H. E. . . . Rauch, S. (2008). Augmentation of behavior therapy with D-cycloserine for obsessive-compulsive disorder. American Journal of Psychiatry, 165, 335-341. (Pubitemid 351704489)
69. Williams, M. T., Farris, S. G., Turkheimer, E., Pinto, A., Ozanick, K., Franklin, M. E. . . . Foa, E. B. (2011). Myth of the pure obsessional type in obsessive-compulsive disorder. Depression and Anxiety, 28, 495-500.
70. World Health Organization. (2005, January). Mental health: Facing the challenges, building solutions. Paper read at Report from the WHO European Ministerial Conference, Helsinki.